CIITA: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
Line 31: Line 31:
{{medicine-stub}}
{{medicine-stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 06:15, 17 March 2025

CIITA (Class II Major Histocompatibility Complex Transactivator) is a protein that in humans is encoded by the CIITA gene. CIITA is a key regulator in the immune system, specifically in the expression of the Class II Major Histocompatibility Complex (MHC).

Function[edit]

CIITA is a transcription factor that regulates the expression of Class II MHC genes. The Class II MHC proteins are essential for the immune system's ability to present antigens to the T cells, a process known as antigen presentation. Without CIITA, the Class II MHC genes are not expressed, which can lead to a weakened immune response.

Structure[edit]

The CIITA protein is composed of several domains, each with a specific function. The N-terminal domain is involved in transcriptional activation, while the C-terminal domain is responsible for the protein's nuclear localization. The central region of the protein contains a proline-rich domain and a leucine-rich repeat (LRR) domain, which are thought to be involved in protein-protein interactions.

Clinical significance[edit]

Mutations in the CIITA gene can lead to a rare immunodeficiency disorder known as Bare Lymphocyte Syndrome type II (BLS II). This condition is characterized by a lack of MHC Class II expression, leading to severe combined immunodeficiency.

See also[edit]

References[edit]

<references />


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!